These could be more accurate models to use for the molecular and phenotypic characterizations of CFC than the first mouse model of this disease, which was generated by expressing low levels of a constitutively active Braf allele (Urosevic et al., 2011). The gene discussed is BRAF; the disease is cardiofaciocutaneous syndrome.